GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TRACON Pharmaceuticals Inc (STU:T051) » Definitions » Institutional Ownership

TRACON Pharmaceuticals (STU:T051) Institutional Ownership : 8.66% (As of Jun. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is TRACON Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TRACON Pharmaceuticals's institutional ownership is 8.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TRACON Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TRACON Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 68.10%.

TRACON Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for TRACON Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TRACON Pharmaceuticals Institutional Ownership Chart

TRACON Pharmaceuticals Historical Data

The historical data trend for TRACON Pharmaceuticals can be seen below:

2020-11-30 2020-12-31 2021-01-31 2021-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31
Institutional Ownership 1.00 2.88 3.00 2.76 8.58 10.55 10.61 10.99 8.67 8.66

TRACON Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

TRACON Pharmaceuticals (STU:T051) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TRACON Pharmaceuticals Inc (STU:T051) » Definitions » Institutional Ownership
Comparable Companies
XBIO SNGX TSOI NAVB ABVC PALI TENX IKT HOTH IMPL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
TCON:USA
Address
4350 La Jolla Village Drive, Suite 800, San Diego, CA, USA, 92122
Website
https://www.traconpharma.com
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.

TRACON Pharmaceuticals (STU:T051) Headlines

No Headlines